[Skip to Content]
[Skip to Content Landing]
Views 532
Citations 0
Research Letter
June 2017

Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults

Author Affiliations
  • 1Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts
  • 2Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts
  • 3Boston Health Care for the Homeless Program, Boston, Massachusetts
  • 4Division of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
  • 5Boston University School of Medicine, Boston, Massachusetts
JAMA Intern Med. 2017;177(6):880-882. doi:10.1001/jamainternmed.2017.0358

Approximately 44% of homeless adults are hepatitis C virus (HCV)-infected.15 Historically, homeless and marginally housed (HMH) adults have faced barriers to HCV treatment. New, interferon-free therapies have excellent cure rates and improved tolerability, reducing barriers for treatment.6 To our knowledge, no published studies have documented the treatment of HMH populations with these therapies. The Boston Health Care for the Homeless Program (BHCHP) began treating HMH adults with oral agents in 2014.

First Page Preview View Large
First page PDF preview
First page PDF preview